Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
1.845
-0.035 (-1.86%)
Nov 21, 2024, 11:58 AM EST - Market open
Virax Biolabs Group Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 21, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Market Capitalization | 8 | 2 | 11 | - | - | - |
| Market Cap Growth | -84.34% | -84.34% | - | - | - | - |
| Enterprise Value | 4 | -4 | 6 | - | - | - |
| Last Close Price | 1.88 | 0.72 | 6.95 | - | - | - |
| PS Ratio | 59.16 | 10.83 | 1262.87 | - | - | - |
| PB Ratio | 0.56 | 0.33 | 1.21 | - | - | - |
| P/TBV Ratio | 0.32 | 0.32 | 1.21 | - | - | - |
| EV/Sales Ratio | 52.93 | - | 701.38 | - | - | - |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.02 | - | -0.21 | -0.62 |
| Asset Turnover | 0.02 | 0.02 | 0.00 | - | 3.98 | - |
| Inventory Turnover | 0.64 | 0.64 | 0.44 | - | - | - |
| Quick Ratio | 23.01 | 23.01 | 10.35 | 0.02 | 0.02 | 0.02 |
| Current Ratio | 25.94 | 25.94 | 10.61 | 0.04 | 0.05 | 0.02 |
| Return on Equity (ROE) | -95.98% | -95.98% | -141.63% | - | - | - |
| Return on Assets (ROA) | -49.90% | -49.90% | -72.67% | -2453.52% | -1294.67% | - |
| Return on Capital (ROIC) | -52.89% | -52.89% | -91.03% | - | - | - |
| Earnings Yield | -80.61% | -397.61% | -50.48% | - | - | - |
| FCF Yield | -88.20% | -425.13% | -38.66% | - | - | - |
| Buyback Yield / Dilution | -88.75% | -88.75% | -11.15% | -297.67% | -130.43% | - |
| Total Shareholder Return | -88.75% | -88.75% | -11.15% | -297.67% | -130.43% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.